Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success

How 1 sources are covering this

• STATCenter·2h ago

  Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success

  Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA vaccines to target tumors.

  Read at STAT →